| galantamine hydrobromide / Generic mfg. |
NCT00035204: A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease |
|
|
| Completed | 4 | 63 | US | galantamine | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Ortho-McNeil Neurologics, Inc. | Alzheimer Disease | | 05/03 | | |
NCT00234637: Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment |
|
|
| Completed | 4 | 204 | Europe | Rivastigmine, memantine | Novartis | Alzheimer's Disease | 06/05 | 06/05 | | |
NCT00216515: The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer Type |
|
|
| Completed | 4 | 102 | RoW | galantamine hydrobromide | Janssen Korea, Ltd., Korea | Alzheimer Disease | | 11/05 | | |
NCT00320736: Galantamine for Cognition in People With Schizophrenia |
|
|
| Completed | 4 | 20 | US | galantamine | North Suffolk Mental Health Association, Janssen Medical Affairs | Schizophrenia, Schizoaffective Disorder | | 05/06 | | |
NCT00176423: Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia |
|
|
| Completed | 4 | 117 | US | galantamine | University of Maryland, Baltimore, Stanley Medical Research Institute, Ortho-McNeil Neurologics, Inc. | Schizophrenia, Schizoaffective Disorder | 12/06 | 12/06 | | |
NCT00626613: The Relationship Between Risperdal Treatment and Quality of Life in Patients With Alzheimer's Disease and Behavioural and Psychological Symptoms of Dementia (BPSD) |
|
|
| Unknown status | 4 | | RoW | Risperdal,reminyl | Jinan Mental Hospital, Johnson & Johnson | Dementia, Alzheimer's Disease | | | | |
NCT01054976: The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's Disease |
|
|
| Completed | 4 | 99 | RoW | Galantamine | Janssen Korea, Ltd., Korea | Alzheimer's Disease | 02/09 | 02/09 | | |
| Terminated | 4 | 1 | Europe | Galantamine | Janssen-Cilag, S.A. | Alzheimer Disease | 06/11 | 06/11 | | |
NCT01478633: Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil |
|
|
| Completed | 4 | 102 | Japan | Galantamine | Janssen Pharmaceutical K.K. | Alzheimer's Disease | 06/13 | 06/13 | | |
NCT01529619: Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors |
|
|
| Completed | 4 | 52 | Japan | Rivastigmine transdermal patch | Novartis Pharmaceuticals, Ono Pharmaceutical Co. Ltd | Alzheimer's Disease | 12/13 | 12/13 | | |
ENA1stepswitch, NCT02703636: NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients. |
|
|
| Completed | 4 | 118 | Japan | Rivastigmine Patch, rivastigmine | Novartis Pharmaceuticals | Mild to Moderate Alzheimer's Disease | 05/18 | 05/18 | | |
